Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELURL EPINETTES-PHARMA : revenue, balance sheet and financial ratios

SELURL EPINETTES-PHARMA is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NANTES (44000), this company of category PME shows in 2020 a net income positive of 63 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELURL EPINETTES-PHARMA (SIREN 822418398)
Indicator 2020 2019 2018 2017
Revenue N/C N/C N/C N/C
Net income 62 786 € 67 708 € 49 615 € 46 777 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2020, SELURL EPINETTES-PHARMA generates positive net income of 63 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2020: 47 k€ -> 63 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

62 786 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 164%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

164.032%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.427%

Solvency indicators evolution
SELURL EPINETTES-PHARMA

Sector positioning

Debt ratio
164.03 2020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average -13 pts over 3 years

In 2020, the debt ratio of SELURL EPINETTES-PHARMA (164.03) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
31.43% 2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Average +11 pts over 3 years

In 2020, the financial autonomy of SELURL EPINETTES-PHARMA (31.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 172.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

172.607

Liquidity indicators evolution
SELURL EPINETTES-PHARMA

Sector positioning

Liquidity ratio
172.61 2020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Average -5 pts over 3 years

In 2020, the liquidity ratio of SELURL EPINETTES-PHARMA (172.61) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELURL EPINETTES-PHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of SELURL EPINETTES-PHARMA is estimated at 887 333 € (range 591 661€ - 1 197 251€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
591k€ 887k€ 1197k€
887 333 € Range: 591 661€ - 1 197 251€
NAF 5 année 2020

Valuation method used

Net Income Multiple
62 786 € × 14.1x = 887 333 €
Range: 591 661€ - 1 197 252€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELURL EPINETTES-PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELURL EPINETTES-PHARMA

What is the revenue of SELURL EPINETTES-PHARMA ?

The revenue of SELURL EPINETTES-PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is SELURL EPINETTES-PHARMA profitable?

Yes, SELURL EPINETTES-PHARMA generated a net profit of 63 k€ in 2020.

Where is the headquarters of SELURL EPINETTES-PHARMA ?

The headquarters of SELURL EPINETTES-PHARMA is located in NANTES (44000), in the department Loire-Atlantique.

Where to find the tax return of SELURL EPINETTES-PHARMA ?

The tax return of SELURL EPINETTES-PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELURL EPINETTES-PHARMA operate?

SELURL EPINETTES-PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.